DRREDDY's weekly performance was disappointing, with a return of -5.46% and a max drawdown of the same magnitude, indicating a significant decline in value. The stock's volatility was high at 16.27%, and its Sharpe ratio of -1.36 suggests that the return was not justified by the level of risk taken. Compared to its peers, DRREDDY underperformed, with only SUNPHARMA coming close to its negative return. Overall, the stock was relatively risky this week.

[Volatility: 16.27%]